Brazil's lifelike doll craze goes from shopping malls to state legislatures
SAO PAULO (AP) — Videos featuring emotional moments with hyper-realistic baby dolls have sparked both online fascination and political debate in Brazil, with lawmakers even bringing the lifelike dolls into legislatures.
Influencers have staged situations such as birth simulations and strolls in shopping malls with the hand-crafted baby figures, known as 'reborn' dolls, creating videos that have gone viral.
In Rio de Janeiro, the city council has passed a bill honoring those who make the lifelike dolls, pending Mayor Eduardo Paes' signature. Meanwhile, legislators elsewhere across the country have debated fines for those seeking medical help for such dolls, following a video allegedly showing a woman taking one to a hospital.
Lawmakers have brought the dolls into legislative chambers.
On Tuesday, Joao Luiz, a state lawmaker from Amazonas, appeared with a doll at the State House to announce plans to ban reborn dolls from receiving care in the state's public health system. However, local media reported that health authorities had never recorded any such cases.
Last week, congresswoman Talíria Petrone criticized the attention her colleagues were giving to the issue. 'Can we focus on what really matters? If someone wants to have a doll, let them. I have two real children and they're more than enough work,' she said.
Dozens of 'reborn mothers' gathered at Villa Lobos Park, in Sao Paulo, on Saturday for a 10th annual meet-up. Participants say criticism should be aimed at attention-seeking influencers, not the broader community.
The hyper-realistic baby dolls are often used for grief therapy or parenting practice.
Berenice Maria, a nursing assistant and longtime collector who owns eight dolls, says they offer emotional comfort. 'I love reborns, despite the hate we see out there,' she said. 'I want the right to go out with them … go to the mall, go to the park.'
Daniela Baccan, co-owner of a reborn doll shop in Campinas, Sao Paulo, said dolls sell from 700 reais ($124) to nearly 10,000 reais (nearly $1,800).
With the rising controversy, safety concerns are increasing.
'We're locking up the store more, adding cameras,' Baccan said. 'But at the same time, online demand has increased, and the store is seeing a much higher flow of people.'
___
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
42 minutes ago
- Yahoo
🎥 Neymar sent off in possible Santos farewell, silly red card
In what could be his last game for his home club FC Santos, Neymar certainly didn't cover himself in glory and received a truly curious yellow card. Due to injury, it was only his second start since his return in January. This was also over after 76 minutes because the Brazilian scored a goal in the style of the Hand of God. Advertisement The already warned superstar let himself be carried away with this action, but apparently forgot that, unlike Diego Maradona, he would be exposed by about 100 camera angles during his cheating action. Neymar quickly became the laughing stock on the net, instead of the heroic goal scorer of his team. Santos lost the duel against Botafogo 1-0 with a man down and is currently in a relegation spot after eleven matchdays. Since Neymar's contract expires on June 30 and the Brazilian league is on hold due to the Club World Cup until mid-July, this inglorious action could actually have been his last for Santos. The signs are currently pointing to another club change. Advertisement This article was translated into English by Artificial Intelligence. You can read the original version in 🇩🇪 here. 📸 Miguel Schincariol - 2025 Getty Images
Yahoo
3 hours ago
- Yahoo
Nations urged to make UN summit a 'turning point' for oceans
Nations will be under pressure to deliver more than just rhetoric at a UN oceans summit in France next week, including much-needed funds to better protect the world's overexploited and polluted seas. The third UN Ocean Conference (UNOC) seeks to build global unity and raise money for marine conservation even as nations disagree over deep-sea mining, plastic trash and overfishing. On Sunday, hosts France are expecting about 70 heads of state and government to arrive in Nice for a pre-conference opening ceremony, including Brazilian President Luiz Inacio Lula da Silva. Oceans are "in a state of emergency" and the June 9 to 13 meeting "will not be just another routine gathering", said UN under-secretary-general Li Junhua. "There's still time to change our course if we act collectively," he told reporters. Most countries are expected to send ministers or lower-level delegates to the summit, which does not carry the weight of a climate COP or UN treaty negotiation or make legally binding decisions. The United States under President Donald Trump -- whose recent push to fast-track seabed mining in international waters sparked global outrage -- is unlikely to send a delegation at all. France has promised the summit will do for ocean conservation what the Paris Agreement did for global climate action. Nations present are expected to adopt a "Nice Declaration": a statement of support for greater ocean protection, coupled with voluntary additional commitments by individual governments. Greenpeace has slammed the text -- which was agreed after months of negotiation -- as "weak" and said it risked making Nice "a meaningless talking shop". Pacific leaders are expected to turn out in force and demand, in particular, concrete financial commitments from governments. "The message is clear: voluntary pledges are not enough", Ralph Regenvanu, environment minister for Vanuatu, told reporters. The summit will also host business leaders, international donors and ocean activists, while a science convention beforehand is expected to draw 2,000 ocean experts. - Temperature check - France has set a high bar of securing by Nice the 60 ratifications needed to enact a landmark treaty to protect marine habitats outside national jurisdiction. So far, only 28 countries and the European Union have done so. Olivier Poivre d'Arvor, France's oceans envoy, says that without the numbers the conference "will be a failure". Bringing the high seas treaty into force is seen as crucial to meeting the globally-agreed target of protecting 30 percent of oceans by 2030. The summit could also prove influential on other higher-level negotiations in the months ahead and provide "a temperature check in terms of ambition", said Megan Randles, head of Greenpeace's delegation at the Nice conference. In July the International Seabed Authority will deliberate over a long-awaited mining code for the deep oceans, one that Trump has skirted despite major ecological concerns. That comes in the face of growing calls for governments to support an international moratorium on seabed mining, something France and roughly 30 other countries have already backed. And in August, nations will again seek to finalise a binding global treaty to tackle plastic trash after previous negotiation rounds collapsed. Countries and civil society groups are likely to use the Nice meeting to try to shore up support ahead of these proceedings, close observers said. - Turning point - Nations meeting at UN conferences have struggled recently to find consensus and much-needed finance to combat climate change and other environmental threats. Oceans are the least funded of all the UN's sustainable development goals but it wasn't clear if Nice would shift the status quo, said Angelique Pouponneau, a lead negotiator for the Alliance of Small Island States. "With so many competing crises and distractions on the global agenda, it's hard to be confident that the level of ambition needed will actually show up," Pouponneau told AFP. Costa Rica, which is co-hosting the conference with France, said public and private commitments of $100 billion with "clear timelines, budgets and accountability mechanisms" could be expected. "This is what is different this time around -- zero rhetoric, maximum results," Maritza Chan Valverde, Costa Rica's permanent representative to the UN, told reporters. Pepe Clarke, oceans practice leader from WWF, told AFP there was "an understandable level of scepticism about conferences". But he said Nice must be "a turning point... because to date the actions have fallen far short of what's needed to sustain a healthy ocean into the future". np-aag/klm/phz
Yahoo
6 hours ago
- Yahoo
Deadly superbugs thrive as access to antibiotics falters in India
It's a grim paradox, doctors say. On the one hand, antibiotics are being overused until they no longer work, driving resistance and fuelling the rise of deadly superbugs. On the other hand, people are dying because they can't access these life-saving drugs. A new study by the non-profit Global Antibiotic Research and Development Partnership (GARDP) looked at access to antibiotics for nearly 1.5 million cases of carbapenem-resistant Gram-negative (CRGN) infections across eight major low- and middle-income countries, including India, Brazil and South Africa. CRGN bacteria are superbugs resistant to last-line antibiotics - yet only 6.9% of patients received appropriate treatment in the countries studied. India bore the lion's share of CRGN infections and treatment efforts, procuring 80% of the full courses of studied antibiotics but managing to treat only 7.8% of its estimated cases, the study in The Lancet Infectious Diseases journal reports. (A full drug course of antibiotics refers to the complete set of doses that a patient needs to take over a specific period to fully treat an infection.) Common in water, food, the environment and the human gut, Gram-negative bacteria cause infections such as urinary tract infections (UTIs), pneumonia and food poisoning. They can pose a serious threat to newborns and the elderly alike. Especially vulnerable are hospital patients with weakened immunity, often spreading rapidly in ICUs and proving difficult - and sometimes impossible - to treat. Treating carbapenem-resistant Gram-negative bacterial infections is doubly difficult because those bacteria are resistant to some of the most powerful antibiotics. "These infections are a daily reality across all age groups," says Dr Abdul Gaffar, infectious disease consultant at Apollo Hospital in India's Chennai city. "We often see patients for whom no antibiotic works - and they die." The irony is cruel. While the world tries to curb antibiotic overuse, a parallel tragedy plays out quietly in poorer nations: people dying from treatable infections because the right drugs are out of reach. "For years, the dominant narrative has been that antibiotics are being overused, but the stark reality is that many people with highly drug-resistant infections in low- and middle-income countries are not getting access to the antibiotics they need," says Dr Jennifer Cohn, GARDP's Global Access Director and senior author of the study. India's 'blockbuster' drugs to take on deadly superbugs India facing a pandemic of antibiotics-resistant superbugs The study examined eight intravenous drugs active against carbapenem-resistant bacteria - ranging from older antibiotics including Colistin to newer ones such as Ceftazidime-avibactam. Of the few available drugs, Tigecycline was the most widely used. Researchers blame the treatment gap on weak health systems and limited access to effective antibiotics. For example, only 103,647 full treatment courses were procured of Tigecycline across eight countries - far short of the 1.5 million patients who needed them, the study found. This highlighted a major shortfall in the global response to drug-resistant infections. What prevents patients with drug-resistant infections in India from getting the right antibiotics? Physicians point to multiple barriers - reaching the right health facility, getting accurate diagnostic tests, and accessing effective drugs. Cost remains a major hurdle, with many of these antibiotics priced far beyond the reach of poorer patients. "Those who can afford these antibiotics often overuse them; those who can't, don't get them at all," says Dr Gaffar. "We need a system that ensures access for the poor and prevents misuse by the well-to-do." To improve access, these drugs must be made more affordable. To prevent misuse, stronger regulation is key. "Ideally, every antibiotic prescription in hospitals should require a second sign-off - by an infection specialist or microbiologist," says Dr Gaffar. "Some hospitals do this, but most don't. With the right oversight, regulators can ensure this becomes standard practice." To fix the access problem and curb misuse, both smarter policies and stronger safeguards are essential, say researchers. But access alone won't solve the crisis - the pipeline of new antibiotics is drying up. The decline in antibiotic R&D - and the limited availability of existing drugs - is a global issue. India bears one of the world's heaviest burdens of antimicrobial resistance (AMR), but it may also hold the key to combating it - both at home and globally, researchers say. "India is also one of the largest markets for new antibiotics and can successfully advocate for the development and access of new antibiotics," says Dr Cohn. With a strong pharmaceutical base, the country is emerging as a hub for AMR innovation, from promising new antibiotics to advanced diagnostics. Dr Cohn says India can strengthen its antibiotic response by generating local data to better estimate needs and pinpoint gaps in the care pathway. This would allow for more targeted interventions to improve access to the right drugs. Innovative models are already emerging - Kerala state, for instance, is using a "hub-and-spoke approach" to support lower-level facilities in managing serious infections. Coordinated or pooled procurement across hospitals or states could also reduce the cost of newer antibiotics, as seen with cancer drug programs, researchers say. Without access to the right antibiotics, modern medicine begins to unravel - doctors risk losing the ability to safely perform surgery, treat complications in cancer patients, or manage everyday infections. "As an infectious disease doctor, I see appropriate use as one part - but only one part - of access," says Dr Gaffar. "When we get new antibiotics, it's important to save them on one hand - and save them for right patients." Clearly, the challenge is not just to use antibiotics wisely, but to ensure they reach those who need them most.
